Cell & Gene Therapies State of the Industry Briefing

About the Briefing

Join us for the Alliance for Regenerative Medicine’s 10th Annual Cell & Gene Therapies State of the Industry Briefing, a top-level gathering for key stakeholders in the field. This event – which is free and open to the public – will include ARM’s annual yearly update on the sector’s progress, as well as two panels featuring top CEOs and executives highlighting future inflection points for cell and gene therapies in 2020. With an anticipated audience of over 500, this session is the largest cell and gene therapy-focused event taking place during JP Morgan week.

2020 Agenda

8:00am – 8:20am | Introduction & Industry Update

Janet Lambert, CEO, Alliance for Regenerative Medicine

8:20am – 9:05am | Emerging Cell Therapies for Cancer

Usman “Oz” Azam, President & CEO, Tmunity Therapeutics (moderator)
Claudia Mitchell, Senior VP, Product & Portfolio Strategy, Astellas
Samarth Kulkarni, CEO, CRISPR
Pascal Touchon, CEO, Atara Biotherapeutics
Matthew Kane, Co-Founder and CEO, Precision BioSciences

9:05am – 9:50am | Next Generation Gene and Cell Technologies

Timothy Miller, President & CEO, Gene Therapy Newco (moderator)
Laurence Cooper,
CEO, Ziopharm
Emile Nuwaysir,
President & CEO, BlueRock Therapeutics
Tim Lu,
Co-Founder and CEO, Senti Bio
Shelia Mikhail, 
CEO, AskBio

9:50am | Program Close

 

View the 2019 Webcast

Couldn’t attend this year’s Cell & Gene Therapies State of the Industry Briefing in-person or looking to have a copy of the slides to reference again? View the full webcast below and download the 2019 Industry Update PPT presentation.

Click to accept cookies and enable this content

 

To see all three of the video options click on the horizontal bars in the upper left corner.

Download Presentation

 

Date:
January 13, 2020
8:00am - 9:50am

Location:
Parc 55 San Francisco, A Hilton Hotel

55 Cyril Magnin St.
San Francisco, CA 94102

Who Attends?

Over 500 of the cell and gene therapy field’s top stakeholders including company founders, C-level business executives, investors, media, patient advocates and academic leaders interested in learning more on the sector’s recent advances and outlook for the industry in the coming year.


Held In Conjunction With:

 

 

 

 

 

Questions?
Please contact Jeanette Lazusky at jlazusky@alliancerm.org.